Search - tctmd.com

Displaying 121 - 140 of 183

Sort: Relevancy | Date

News Daily News

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Todd Neale

November 17, 2014

News Daily News

急性高血糖使AMI后预后恶化

October 24, 2014

News Daily News

La Hiperglucemia Aguda Empeora el Pronóstico Post-IAM

October 24, 2014

News Daily News

Acute Hyperglycemia Worsens Post-AMI Prognosis

October 24, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Daily News

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

October 10, 2014

News Daily News

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

October 10, 2014

News Daily News

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

October 10, 2014

Presentation TCT 2014

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, Frederick Feit

September 16, 2014

Presentation TCT 2014

PCI Outcomes in Diabetic Patients Outside the United States and European Union

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Alfredo E. Rodriguez

September 13, 2014

Presentation TCT 2014

Is There a Role for PCI in Revascularization of Diabetic Patients with Multivessel Disease?

Presenter: Roxana Mehran, Mohamed Sobhy, Habib Gamra

September 13, 2014

Presentation TCT 2014

PCI vs CABG: PCI for Most!

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Gregg W. Stone

September 13, 2014

Presentation TCT 2014

PCI vs CABG: Surgery for Most!

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Michael E. Farkouh

September 13, 2014

News Daily News

联合血运重建有望给糖尿病患者带来福音

L.A. McKeown

July 24, 2014

News Daily News

Hybrid Revascularization a Promising Option for Diabetic Patients

L.A. McKeown

July 24, 2014

News Daily News

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

May 30, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

Presentation

Trimetazidine Impacts on Myocardial Injury and CIN in Diabetic Patients with RD Undergoing Elective PCI

Presenter: Mohamed A. Shehata

May 27, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

Advertisement

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

急性高血糖使AMI后预后恶化

La Hiperglucemia Aguda Empeora el Pronóstico Post-IAM

Acute Hyperglycemia Worsens Post-AMI Prognosis

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

PCI Outcomes in Diabetic Patients Outside the United States and European Union

Is There a Role for PCI in Revascularization of Diabetic Patients with Multivessel Disease?

PCI vs CABG: PCI for Most!

PCI vs CABG: Surgery for Most!

联合血运重建有望给糖尿病患者带来福音

Hybrid Revascularization a Promising Option for Diabetic Patients

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

Trimetazidine Impacts on Myocardial Injury and CIN in Diabetic Patients with RD Undergoing Elective PCI

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content